Contact

All Stories

  1. Targeting metabolic dysfunction-associated steatotic liver disease with phytosomal silymarin and piperine: A natural alternative to fenofibrate in a rat model

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 2025, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  2. Biochemical and Molecular Comparison of UMOD and SERPINA4 SNPs in Kidney Failure Susceptibility and Progression

    Article • Egyptian Journal of Chemistry, September 2025, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  3. Suppnonsense-mediated decay-linked mutations in SARS-CoV-2 and their association with COVID-19 disease severity

    Article • BMC Infectious Diseases, September 2025, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  4. Serum-derived hsa_circ_101555 as a Diagnostic Biomarker in Non-hepatocellular Carcinoma Chronic Liver Disease: A Phase II Cross-sectional Study

    Article • Gene Expression, September 2025, Xia & He Publishing

    Dr. Nashwa El-Khazragy

  5. Exploring the Link Between IL-6 rs1800795 G > C SNP and the Severity of Epstein-Barr Virus-Associated Multiple Sclerosis: Potential Impact on Cognitive Impairment

    Article • Molecular Neurobiology, July 2025, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  6. Desmoglein-3 autoantibodies in tissues of oral lichen planus patients and its correlation with disease severity: case-control study

    Article • BMC Oral Health, June 2025, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  7. Forensic saliva stains aging, using reverse transcription real-time PCR combined with a multidimensional prediction model of specific mRNA markers

    Article • Egyptian Journal of Forensic Sciences, April 2025, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  8. The Potential Oncogenic Role of Serum-derived hsa_circ_101555 as a Non-invasive Diagnostic/Prognostic Marker in Patients with Hepatocellular Carcinoma

    Article • Gene Expression, March 2025, Xia & He Publishing

    Dr. Nashwa El-Khazragy

  9. Successful Treatment of Female Pattern Hair Loss with Injection of Autologous Adipose-derived Adult Stem Cells: A Controlled Clinical, Trichoscopic, and Immunohistochemical Trial

    Article • International Journal of Trichology, March 2025, Wolters Kluwer Health

    Dr. Nashwa El-Khazragy

  10. Overexpression of lncRNAs HOTAIR and MALAT1 While Downexpression of lncRNA PANDA Predict the Resistance of Diffuse Large B‐Cell Lymphoma to R‐CHOP Chemoimmunotherapy

    Article • International Journal of Laboratory Hematology, February 2025, Wiley

    Dr. Nashwa El-Khazragy

  11. Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation

    Article • Annals of Hematology, January 2025, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  12. Combined replacement of lnc-MEG3 and miR-155 elicit tumor suppression in multiple myeloma

    Article • Epigenomics, January 2025, Taylor & Francis

    Dr. Nashwa El-Khazragy

  13. Cracking the code: lncRNA-miRNA-mRNA integrated network analysis unveiling lncRNAs as promising non-invasive NAFLD biomarkers toward precision diagnosis

    Article • Computational Biology and Chemistry, January 2025, Elsevier

    Dr. Nashwa El-Khazragy

  14. Bee venom exhibits anti-cancer effects on tongue carcinoma cells by arresting cell cycle, inducing apoptosis, and suppressing cell migration

    Article • Journal of Applied Oral Science, January 2025, FapUNIFESP (SciELO)

    Dr. Nashwa El-Khazragy

  15. NGAL as a biomarker for early diagnosis of acute kidney injury in the ICU

    Article • GSC Biological and Pharmaceutical Sciences, December 2024, GSC Online Press

    Dr. Nashwa El-Khazragy

  16. Significance of the influence of patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 polymorphism on non alcoholic fatty liver disease

    Article • african journal of gastroenterology and hepatology, October 2024, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  17. 1PNPLA3 and Neutophil Lymphocyte Ratio as a Genetic and Inflammatory Predictors of Histopathological Severity by Liver Biopsy in Nonalcoholic Fatty Liver Disease

    Article • QJM, October 2024, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  18. Autologous Cultured Fibroblast Cell Therapy for Treatment of Stria Alba

    Article • QJM, October 2024, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  19. Blood-Based Molecular Biomarkers as Predictors for Respiratory Distress Syndrome in Infants of Diabetic Mothers

    Article • QJM, October 2024, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  20. Natural Anticoagulants in Transfusion Dependent Beta-Thalassemia Patients

    Article • QJM, October 2024, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  21. Assessment of 11 β-Hydroxysteroid Dehydrogenase Type I Activity in Patients with Psoriasis Vulgaris

    Article • QJM, October 2024, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  22. Evaluation of the Cytotoxic Effects of MicroRNA-34a: An Experimental Interference in Human Cancer Cell Lines

    Article • Egyptian Journal of Chemistry, September 2024, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  23. Comparison of the efficacy of Er,Cr:YSGG laser on oral biofilm removal from implant surfaces with various application times for the treatment of peri-implantitis defects: ex vivo study

    Article • BMC Oral Health, August 2024, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  24. Assessment of 11 β-Hydroxysteroid Dehydrogenase Type I Activity in Patients With Psoriasis Vulgaris: A Novel Insight Into the Pathogenesis of the Disease

    Article • Cureus, August 2024, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  25. Effect of Ginger and Turmeric Extracts Enhanced Formula on Non-Alcoholic Fatty Liver Induced by Oxy-Tetracycline in Wistar Rats

    Article • Egyptian Journal of Chemistry, August 2024, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  26. MICRORNA-137 AND MICRORNA-106B ARE NOVEL MYOCARDIAL ISCHEMIA/INFLAMMATIONDEPENDENT BIOMARKERS WITH HIGH DIAGNOSTIC SENSITIVITY AND SPECIFICITY FOR ACUTE CORONARY SYNDROME (ACS)

    Article • Journal of the American College of Cardiology, April 2024, Elsevier

    Dr. Nashwa El-Khazragy

  27. The tumor suppressor effect of miRNA 200-c-3p on A549 non-small cell lung cancer cell line is associated with down-regulation of programmed cell death ligand 1; an immune-check point mechanism

    Article • Cellular and Molecular Biology, March 2024, CMB Association

    Dr. Nashwa El-Khazragy

  28. The Expression Profile of MicroRNA LET-7a-5p in Children with Idiopathic Thrombocytopenic Purpura

    Article • Egyptian Journal of Chemistry, February 2024, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  29. Evaluation of klotho expression on peripheral blood lymphocytes among hemodialysis patients and its possible contribution to their immuno-compromised status

    Article • Egyptian journal of Immunology, January 2024, Egyptian Association of Immunologists

    Dr. Nashwa El-Khazragy

  30. In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

    Article • RSC Advances, January 2024, Royal Society of Chemistry

    Dr. Nashwa El-Khazragy

  31. The MiR-200c/FOXP3 Network: A Promising Biomarker for Predicting Trastuzumab Response in HER2-Positive Breast Cancer

    Article • Technology in Cancer Research & Treatment, January 2024, SAGE Publications

    Dr. Nashwa El-Khazragy

  32. miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis

    Article • Diagnostic Microbiology and Infectious Disease, November 2023, Elsevier

    Dr. Nashwa El-Khazragy

  33. Nourin miRNAs: novel biomarkers highly expressed in unstable angina patients with normal ECG and negative hs-troponin and dropped post percutaneous coronary intervention

    Article • European Heart Journal, November 2023, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  34. Impact of p53-dependent Networks on Prognosis of chronic lymphocytic leukemia

    Article • Egyptian Journal of Applied and Pure Science, October 2023, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  35. Integrated Bioinformatics Analysis Confirms the Diagnostic Value of Nourin-Dependent miR-137 and miR-106b in Unstable Angina Patients

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Dr. Nashwa El-Khazragy

  36. Assessment of Tissue Expression of PIR2/RNF144b Protein in the Different Stages of Endometrial Cancer

    Article • QJM, June 2023, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  37. Evaluation of the Diagnostic and Prognostic Potential of Circulating miR-34a in Neonatal Sepsis

    Article • QJM, June 2023, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  38. Evaluation of the Apoptotic Effect of Punicalagin on Tongue Carcinoma Cell ( In-vitro study )

    Article • Ain Shams Dental Journal, June 2023, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  39. Evaluation of Er,Cr:YSGG LASER in flapless functional crown lengthening (A randomized controlled clinical trial with microbial analysis)

    Article • Egyptian Dental Journal, April 2023, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  40. Cyclocreatine Phosphate: A Novel Bioenergetic/Anti-Inflammatory Drug That Resuscitates Poorly Functioning Hearts and Protects against Development of Heart Failure

    Article • Pharmaceuticals, March 2023, MDPI AG

    Dr. Nashwa El-Khazragy

  41. PTEN rs701848 Polymorphism is associated with Trastuzumab Resistance in HER2-positive Metastatic Breast Cancer and predicts Progression-free survival

    Article • Clinical Breast Cancer, December 2022, Elsevier

    Dr. Nashwa El-Khazragy

  42. Abstract 9706: A Novel High Energy Phosphate Source Resuscitates Poorly Functioning Donor Hearts

    Article • Circulation, November 2022, Wolters Kluwer Health

    Dr. Nashwa El-Khazragy

  43. Comparison between Antimicrobial Photodynamic Therapy and Injectable Platelet Rich Fibrin as an adjunct to Non-Surgical Periodontal Treatment (A Randomized Controlled Clinical Trial with Microbiological Assessment)

    Article • Egyptian Dental Journal, October 2022, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  44. Psychological impact of COVID-19 on health care workers: cross-sectional analyses from 14 countries

    Article • Cambridge Prisms Global Mental Health, July 2022, Cambridge University Press

    Dr Shariful Islam, Dr. Nashwa El-Khazragy, Dr Sheikh M Alif

  45. HE4 is a Beneficial Biomarker in Endometrial Adenocarcinoma

    Article • Current Women s Health Reviews, May 2022, Bentham Science Publishers

    Dr. Nashwa El-Khazragy

  46. Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma

    Article • Disease Markers, April 2022, Hindawi Publishing Corporation

    Dr. Nashwa El-Khazragy

  47. Role of miRNA-204 as a putative diagnostic marker in nonsmall-cell lung cancer

    Article • Egyptian Journal of Chest Diseases and Tuberculosis, January 2022, Medknow

    Dr. Nashwa El-Khazragy

  48. Plasmacytoma Variant Translocation-1 as Prognostic Markers in Pediatric Acute Lymphoblastic Leukemia

    Article • The Scientific Journal of Medical Scholar, January 2022, Damietta Faculty of Medicine, Al-Azhar University, Egypt

    Dr. Nashwa El-Khazragy

  49. Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia

    Article • Immunobiology, November 2021, Elsevier

    Dr. Nashwa El-Khazragy

  50. Correction to: Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide

    Article • Annals of Hematology, October 2021, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  51. Assessment of the Oxidative Stress Status in Androgenetic Alopecia in Egyptian Men

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  52. COVID-19: Factors associated with psychological distress, fear, and coping strategies among community members across 17 countries

    Article • Globalization and Health, October 2021, Springer Science + Business Media

    Dr. Nashwa El-Khazragy, Dr Sheikh M Alif, Dr Shariful Islam

  53. Evaluation of Serum level of thrombomodulin in cases with preeclampsia

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  54. Long Non-Coding RNA- PVT1 in Ovarian Cancer as Predictors for Platinum Analogues Resistance

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  55. Serum Amyloid A Level in Women with Unexplained Infertility

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  56. Assessment of Human Nuclear Factor Erythroid 2 Related Factor 2 (NRF2) in Androgenetic Alopecia in Egyptian Men

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  57. Health Risks of Low Dose Of Ionizing Radiation Among Health Care Providers at ain Shams University Hospitals

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  58. The Effect of Platelet Rich Plasma on the Treatment Outcome of Minigraft/NB-UVB Therapy in Stable Vitiligo: Clinical Evaluation and Effect on Tissue levels of bFGF

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  59. Prospective Analysis of Serum HE4 as an Independent Prognostic Factor in Non Small Cell Lung Cancer

    Article • QJM, October 2021, Oxford University Press (OUP)

    Dr. Nashwa El-Khazragy

  60. CLL-393: Knockdown of WEE1 Gene Induces Cytotoxic Effects in Hairy Cell Leukemia

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2021, Elsevier

    Dr. Nashwa El-Khazragy

  61. Poster: CLL-393: Knockdown of WEE1 Gene Induces Cytotoxic Effects in Hairy Cell Leukemia

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2021, Elsevier

    Dr. Nashwa El-Khazragy

  62. Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide

    Article • Annals of Hematology, August 2021, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  63. 3060 – SUPPRESSION OF MIRNA-155A INHIBITS HCV REPLICATION AND INDUCE APOPTOSIS IN LEUKEMIC CELLS

    Article • Experimental Hematology, August 2021, Elsevier

    Dr. Nashwa El-Khazragy

  64. COVID-19: Factors Associated with Psychol­­­ogical Distress, Fear, and Coping Strategies among Community Members Across 17 Countries

    Article • July 2021, Research Square

    Dr. Nashwa El-Khazragy

  65. Nourin-Dependent miR-137 and miR-106b: Novel Biomarkers for Early Diagnosis of Myocardial Ischemia in Coronary Artery Disease Patients

    Article • Diagnostics, April 2021, MDPI AG

    Dr. Nashwa El-Khazragy

  66. Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Dr. Nashwa El-Khazragy

  67. Association between genetic variations in carbamoyl-phosphate synthetase gene and persistent neonatal pulmonary hypertension

    Article • European Journal of Pediatrics, March 2021, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  68. Nourin-Dependent miR-137 and miR-106b: Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients

    Article • Biomolecules, February 2021, MDPI AG

    Dr. Nashwa El-Khazragy

  69. Effect of platelet‐rich plasma on the outcome of mini‐punch grafting procedure in localized stable vitiligo: Clinical evaluation and relation to lesional basic fibroblast growth factor

    Article • Dermatologic Therapy, January 2021, Wiley

    Dr. Nashwa El-Khazragy

  70. CRISPR/Cas9 mediated knock-out of VPREB1 gene induces a cytotoxic effect in myeloma cells

    Article • PLOS One, January 2021, PLOS

    Dr. Nashwa El-Khazragy

  71. COVID-19: Psychol­­­ogical Distress, Fear, and Coping Strategies Among Community Members Across 17 Countries

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Dr. Nashwa El-Khazragy

  72. Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies

    Article • Immunotherapy, December 2020, Future Medicine

    Dr. Nashwa El-Khazragy

  73. Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: a systematic review and meta-analysis

    Article • Expert Review of Anti-infective Therapy, November 2020, Taylor & Francis

    Dr. Nashwa El-Khazragy

  74. Abstract 13051: Nourin-dependent Mirna-137 : A Novel Early Diagnostic Biomarker for Unstable Angina Patients

    Article • Circulation, November 2020, Wolters Kluwer Health

    Dr. Nashwa El-Khazragy

  75. Abstract 13103: Nourin-dependent Mirna-106b : A Novel Early Inflammatory Diagnostic Biomarker for Cardiac Injury

    Article • Circulation, November 2020, Wolters Kluwer Health

    Dr. Nashwa El-Khazragy

  76. Tissue-based long non-coding RNAs “PVT1, TUG1 and MEG3” signature predicts Cisplatin resistance in ovarian Cancer

    Article • Genomics, November 2020, Elsevier

    Dr. Nashwa El-Khazragy

  77. lnc‐HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct‐acting antivirals therapy

    Article • Molecular Carcinogenesis, October 2020, Wiley

    Dr. Nashwa El-Khazragy

  78. THE PROGNOSTIC AND PREDICTIVE VALUE OF SERUM BONE BIOMARKER (CTX) IN PATIENTS WITH BREAST CANCER METASTATIC TO BONE RECEIVING ZOLEDRONIC ACID

    Article • Ain Shams Medical Journal, September 2020, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  79. Lymphoid enhancer-binding factor 1 (LEF-1): a favorable prognostic factor in adult acute myeloid leukemia in Egyptian patients

    Article • Egyptian Journal of Medical Human Genetics, July 2020, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  80. Adverse Health Effects of Low Dose of Ionizing Radiation among Health Care Workers

    Article • Egyptian Journal of Occupational Medicine, April 2020, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  81. EFFECT OF INTENSE PULSED LIGHT ON OXIDATIVE STRESS IN ACNE VULGARIS

    Article • Journal of Recent Advances in Medicine, March 2020, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  82. Upregulation of long noncoding RNA Lnc‐IRF2‐3 and Lnc‐ZNF667‐AS1 is associated with poor survival in B‐chronic lymphocytic leukemia

    Article • International Journal of Laboratory Hematology, February 2020, Wiley

    Dr. Nashwa El-Khazragy

  83. In vitro knock‐out of miR‐155 suppresses leukemic and HCV virus loads in pediatric HCV‐4–associated acute lymphoid leukemia: A promising target therapy

    Article • Journal of Cellular Biochemistry, November 2019, Wiley

    Dr. Nashwa El-Khazragy

  84. Assessment of The Lnc-CCAT1/miR-155a Regulatory Network in Acute Myeloid Leukemia

    Article • Clinical Oncology and Research, September 2019, Science Repository OU

    Dr. Nashwa El-Khazragy

  85. BLASTOCYSTIS SP. ENHANCES OXIDATIVE STRESS-INDUCED CARCINOGENESIS IN COLORECTAL CANCER: IN VIVO EXPERIMENTAL STUDY.

    Article • International Journal of Advanced Research, September 2019, International Journal Of Advanced Research

    Dr. Nashwa El-Khazragy

  86. Upregulation of HOTAIR Predicts Poor Outcome in Acute Myeloid Leukemia

    Article • Clinical Oncology and Research, September 2019, Science Repository OU

    Dr. Nashwa El-Khazragy

  87. Dysregulation of miR-125b Predicts Poor Response to Therapy in Pediatric Acute Lymphoblastic Leukemia

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2019, Elsevier

    Dr. Nashwa El-Khazragy

  88. L-ARGININE SUPPLEMENTATION IMPROVES INSULIN RESISTANCE BY INCREASING THE INSULIN RECEPTOR EXPRESSION IN TYPE II DIABETIC RATS.

    Article • International Journal of Advanced Research, August 2019, International Journal Of Advanced Research

    Dr. Nashwa El-Khazragy

  89. EFFECT OF INTENSE PULSED LIGHT ON OXIDATIVE STRESS IN ACNE VULGARIS

    Article • Journal of Recent Advances in Medicine, July 2019, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  90. The prognostic significance of the long non-coding RNAs “CCAT1, PVT1” in t(8;21) associated Acute Myeloid Leukemia

    Article • Gene, July 2019, Elsevier

    Dr. Nashwa El-Khazragy

  91. Interaction between 12p chromosomal abnormalities and Lnc‐HOTAIR mediated pathway in acute myeloid leukemia

    Article • Journal of Cellular Biochemistry, April 2019, Wiley

    Dr. Nashwa El-Khazragy

  92. IL‐28β gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients

    Article • Journal of Cellular Biochemistry, November 2018, Wiley

    Dr. Nashwa El-Khazragy

  93. Evaluation of Osteopontin and Pokémon genes expression in hepatitis C virus–associated hepatocellular carcinoma

    Article • Journal of Cellular Biochemistry, November 2018, Wiley

    Dr. Nashwa El-Khazragy

  94. Dysregulation of miR‐125b predicts poor response to therapy in pediatric acute lymphoblastic leukemia

    Article • Journal of Cellular Biochemistry, November 2018, Wiley

    Dr. Nashwa El-Khazragy

  95. Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma

    Article • Journal of Cellular Biochemistry, October 2018, Wiley

    marwa matboli, Dr. Nashwa El-Khazragy

  96. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia

    Article • Journal of Cellular Biochemistry, October 2018, Wiley

    Dr. Nashwa El-Khazragy

  97. Correlation between T Stage of the Tumor and Tumor Behavior in Locally Advanced Head and Neck Squamous Cell Carcinoma

    Article • The Egyptian Journal of Hospital Medicine, July 2018, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr. Nashwa El-Khazragy

  98. Role of some circulating MiRNAs on breast cancer diagnosis

    Article • Archives of Physiology and Biochemistry, June 2018, Taylor & Francis

    Prof. Menha Swellam, Dr. Nashwa El-Khazragy

  99. Competing endogenous RNA network: Potential entrants to gene editing in Hepatocellular Carcinoma Gene editing of ceRNA in Hepatocellular Carcinoma

    Article • March 2018, Cold Spring Harbor Laboratory Press

    Dr. Nashwa El-Khazragy

  100. Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma

    Article • Biomarkers in Medicine, March 2018, Future Medicine

    marwa matboli, Dr. Nashwa El-Khazragy

  101. Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients

    Article • Biomarkers in Medicine, January 2018, Future Medicine

    Dr. Nashwa El-Khazragy

  102. P16 Expression Independent of Human Papilloma Virus in Egyptian Patients with Head and Neck Squamous Cell Carcinoma: A Retrospective Study

    Article • International Journal of Science and Research (IJSR), July 2017, International Journal of Science and Research

    Dr. Nashwa El-Khazragy

  103. VITAMIN D3 IMPROVES LIVER FUNCTIONS IN EXPERIMENTALLY INDUCED TYPE II DIABETES MELLITUS IN WISTAR RATS.

    Article • International Journal of Advanced Research, January 2017, International Journal Of Advanced Research

    Dr. Nashwa El-Khazragy

  104. Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma

    Article • Molecular Diagnosis & Therapy, April 2016, Springer Science + Business Media

    Dr. Nashwa El-Khazragy

  105. Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia

    Article • Tumor Biology, February 2016, Springer Science + Business Media

    Dr. Nashwa El-Khazragy